X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
http://www.pharmatimes.com/news/nice_final_guidance_backs_pfizers_lorviqua_1340196
https://www.fiercepharma.com/pharma-asia/big-pharma-s-cancer-drugs-take-50-plus-discount-for-china-s-insurance-scheme
http://www.pharmatimes.com/news/preliminary_nice_no_for_takedas_alunbrig_1254340
https://www.fiercepharma.com/marketing/takeda-alk-drug-alunbrig-trounces-pfizer-s-xalkori-bid-for-earlier-use
https://www.fiercepharma.com/pharma-asia/take-note-i-o-players-bristol-myers-to-sell-opdivo-china-at-half-its-u-s-price-report
http://www.pmlive.com/pharma_news/pfizer_files_third-gen_alk_inhibitor_for_lung_cancer_1221723
http://www.pharmatimes.com/news/first-line_use_of_lung_cancer_drug_zykadia_gets_nhs_nod_1218631
https://www.fiercepharma.com/marketing/opdivo-repatha-and-lynparza-likely-among-china-s-2018-blockbuster-nods-report
https://endpts.com/star-drugs-like-bms-opdivo-astrazenecas-lynparza-will-get-speedy-oks-in-china-this-year-new-report-predicts/
http://www.fiercepharma.com/marketing/takeda-sporting-a-new-look-cancer-portfolio-gears-up-for-roche-battle-alk
http://www.biospectrumasia.com/news/28/8994/fda-grants-approval-for-roches-alk-test-as-cdx-for-zykadia.html
http://www.prnewswire.com/news-releases/roche-announces-fda-approval-of-companion-diagnostic-to-identify-alk-positive-non-small-cell-lung-cancer-patients-300466815.html
http://www.biospace.com/News/novartis-ag-to-lay-off-250-nationwide-with-204/457336/source=TopBreaking?intcid=homepage-seekernewssection-tabtopbreakingnews
http://www.pmlive.com/pharma_news/novartis_zykadia_prepped_to_take_on_xalkori_in_europe_1193675
http://www.nasdaq.com/article/novartis-nvs-lung-cancer-drug-gets-positive-chmp-opinion-cm792969
http://www.pharmafile.com/news/513398/novartis-zykadia-scores-priority-review-and-breakthrough-designation-fda
http://www.fiercepharma.com/marketing/novartis-zykadia-tops-chemo-post-xalkori-lung-cancer-treatment
http://www.fiercepharmamarketing.com/story/pfizer-widens-xalkoris-reach-another-targeted-lung-cancer-approval/2016-03-14
http://www.biospace.com/News/pharma-giant-astrazeneca-plc-in-advanced-talks-to/402878/source=TopBreaking
http://www.fiercepharmamarketing.com/story/roche-challenges-hometown-rival-novartis-new-targeted-lung-cancer-med-alece/2015-12-14
http://www.pharmatimes.com/Article/15-12-08/Five_medicines_cleared_for_use_by_NHS_Scotland.aspx?
http://www.pharmatimes.com/Article/15-11-27/Novartis_launches_lung_cancer_drug_but_fears_limited_access.aspx
http://www.reuters.com/article/2015/11/17/astrazeneca-cancer-tagrisso-idUSL8N13C1TU20151117#OdsURbUtPm7rAgLI.97
http://www.pmlive.com/pharma_news/fda_grants_roches_alectinib_priority_review_for_lung_cancer_817095
http://www.fiercepharma.com/story/novartis-ceo-payers-not-sold-performance-pricing-yet-thatll-change/2015-09-08
http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/003819/WC500187507.pdf
http://www.novartisoncology.com/newsroom/media-releases.jsp?id=1919978&year=2014&page=1&hootPostID=969b5a63827147936a74d8783798986b
http://www.fiercepharmamarketing.com/story/pfizer-merck-kgaa-suit-xalkori-marketing-wave/2015-04-08
https://www.pmlive.com/pharma_news/novartis_cancer_pill_makes_it_onto_uk_early_access_list_697435
http://blogs.fda.gov/fdavoice/index.php/2015/03/fda-continues-to-lead-in-precision-medicine/
http://www.novartis.com/newsroom/media-releases/en/2015/1898130.shtml
http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/02/news_detail_002279.jsp&mid=WC0b01ac058004d5c1
Market Place
Share 
